Punglia RS, D’Amico AV, Catalona WJ, Roehl KA, Kuntz KM: Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen. N Engl J Med 2033; 349: 335-342
Smith DS and Catalona W J: Rate of change in serum prostate specific antigen levels as a method for prostate cancer detection. J Urol 1994; 152: 1163-1167
Yamamoto S, Maruyama T, Kondoh N, Nojima M, Takiuchi H, Hirota S, Shima H: Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate specific antigen between 4 and 10 ng/ml. Int Urol Nephrol (Epub ahead of print), 2007
Stephan C, Jung K, Cammann H, Vogel B, Brux B, Kristiansen G, Rudolph B, Hauptmann S, Lein M, Schnorr D, Sinha P, Loening SA: An artificial neural network considerably improves the diagnostic power of percent free prostate specific antigen in prostate cancer diagnosis: results of a 5-year investigation. Int J Cancer 2002; 99: 466-473
Akaza H, Homma Y, Okada K, Yokoyama M, Usami M, Hirao Y, Tsushima T, Ohashi Y, Aso Y: Prostate Cancer Study Group. A prospective and randomized study of primary hormonal therapy for patients with localized or locally advanced prostate cancer unsuitable for radical prostatectomy: results of the 5-year follow-up. BJU Int 2003; 91: 33-36